OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exosomes and Exosomal Cargos: A Promising World for Ventricular Remodeling Following Myocardial Infarction
Jiacheng Fang, Yuxuan Zhang, Delong Chen, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 4699-4719
Open Access | Times Cited: 28
Jiacheng Fang, Yuxuan Zhang, Delong Chen, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 4699-4719
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance
Xu Guo, Congying Gao, Dong‐Hua Yang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100937-100937
Closed Access | Times Cited: 96
Xu Guo, Congying Gao, Dong‐Hua Yang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100937-100937
Closed Access | Times Cited: 96
Advances in Injectable Hydrogel Strategies for Heart Failure Treatment
Shuyi He, Zaiyuan Zhang, Rifang Luo, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 19
Closed Access | Times Cited: 45
Shuyi He, Zaiyuan Zhang, Rifang Luo, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 19
Closed Access | Times Cited: 45
Exosomal circRNAs: Novel biomarkers and therapeutic targets for urinary tumors
Qiang Liu, Shenglong Li
Cancer Letters (2024) Vol. 588, pp. 216759-216759
Closed Access | Times Cited: 15
Qiang Liu, Shenglong Li
Cancer Letters (2024) Vol. 588, pp. 216759-216759
Closed Access | Times Cited: 15
Exosomes based strategies for cardiovascular diseases: Opportunities and challenges
Hang Li, Jun Zhang, Mingyue Tan, et al.
Biomaterials (2024) Vol. 308, pp. 122544-122544
Closed Access | Times Cited: 6
Hang Li, Jun Zhang, Mingyue Tan, et al.
Biomaterials (2024) Vol. 308, pp. 122544-122544
Closed Access | Times Cited: 6
LIPCAR levels in plasma-derived extracellular vesicles is associated with left ventricle remodeling post-myocardial infarction
Annie Turkieh, Olivia Beseme, Ouriel Saura, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Annie Turkieh, Olivia Beseme, Ouriel Saura, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Extracellular vesicular microRNAs and cardiac hypertrophy
Hai Hu, Xiulian Wang, Hui Yu, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Hai Hu, Xiulian Wang, Hui Yu, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Exosomes Derived from Apelin-Pretreated Mesenchymal Stem Cells Ameliorate Sepsis-Induced Myocardial Dysfunction by Alleviating Cardiomyocyte Pyroptosis via Delivery of miR-34a-5p
Ting Li, Yuechu Zhao, Zhi Cao, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 687-703
Open Access
Ting Li, Yuechu Zhao, Zhi Cao, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 687-703
Open Access
Therapeutic Potential of EVs: Targeting Cardiovascular Diseases
Javier Laura Francés, Christina Pagiatakis, Vittoria Di Mauro, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1907-1907
Open Access | Times Cited: 14
Javier Laura Francés, Christina Pagiatakis, Vittoria Di Mauro, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1907-1907
Open Access | Times Cited: 14
Advances in Nanoparticles in the Prevention and Treatment of Myocardial Infarction
Qidong Wei, Yifei Xiao, Lixin Du, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2415-2415
Open Access | Times Cited: 4
Qidong Wei, Yifei Xiao, Lixin Du, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2415-2415
Open Access | Times Cited: 4
Advances in Purification, Modification, and Application of Extracellular Vesicles for Novel Clinical Treatments
Yasunari Matsuzaka, Ryu Yashiro
Membranes (2022) Vol. 12, Iss. 12, pp. 1244-1244
Open Access | Times Cited: 19
Yasunari Matsuzaka, Ryu Yashiro
Membranes (2022) Vol. 12, Iss. 12, pp. 1244-1244
Open Access | Times Cited: 19
Mesenchymal Stem Cell-Derived Exosomal microRNAs in Cardiac Regeneration
Meghana Bhaskara, Olufisayo Anjorin, Meijing Wang
Cells (2023) Vol. 12, Iss. 24, pp. 2815-2815
Open Access | Times Cited: 11
Meghana Bhaskara, Olufisayo Anjorin, Meijing Wang
Cells (2023) Vol. 12, Iss. 24, pp. 2815-2815
Open Access | Times Cited: 11
Exosomal LncRNAs and CircRNAs in lung cancer: Emerging regulators and potential therapeutic targets
Xia Li, Yunbing Wu, Yue Jin
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1069-1079
Open Access | Times Cited: 3
Xia Li, Yunbing Wu, Yue Jin
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1069-1079
Open Access | Times Cited: 3
Exosomal Non-coding RNA Derived from Mesenchymal Stem Cells (MSCs) in Autoimmune Diseases Progression and Therapy; an Updated Review
Shireen Hamid Farhan, Saade Abdalkareem Jasim, Pooja Bansal, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3091-3108
Closed Access | Times Cited: 2
Shireen Hamid Farhan, Saade Abdalkareem Jasim, Pooja Bansal, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3091-3108
Closed Access | Times Cited: 2
Exosomal non-coding RNAs: Blueprint in colorectal cancer metastasis and therapeutic targets
Bashdar Mahmud Hussen, Sara Tharwat Abdullah, Snur Rasool Abdullah, et al.
Non-coding RNA Research (2023) Vol. 8, Iss. 4, pp. 615-632
Open Access | Times Cited: 7
Bashdar Mahmud Hussen, Sara Tharwat Abdullah, Snur Rasool Abdullah, et al.
Non-coding RNA Research (2023) Vol. 8, Iss. 4, pp. 615-632
Open Access | Times Cited: 7
Mesenchymal Stem Cell-Derived Long Noncoding RNAs in Cardiac Injury and Repair
Talan Tran, Cláudia Ferreira da Cruz, Anthony K. N. Chan, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2268-2268
Open Access | Times Cited: 7
Talan Tran, Cláudia Ferreira da Cruz, Anthony K. N. Chan, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2268-2268
Open Access | Times Cited: 7
Role of toll-like receptor-mediated pyroptosis in sepsis-induced cardiomyopathy
Yixuan Fan, Baoyi Guan, Jianhua Xu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115493-115493
Open Access | Times Cited: 6
Yixuan Fan, Baoyi Guan, Jianhua Xu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115493-115493
Open Access | Times Cited: 6
Regulatory mechanism and promising clinical application of exosomal circular RNA in gastric cancer
Ming Han, Mengyuan Zhang, Mei Qi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Ming Han, Mengyuan Zhang, Mei Qi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Advances in injectable hydrogels for radiation-induced heart disease
Luyao Zhao, Xinyue Wang, Meiling Wen, et al.
Journal of Biomaterials Science Polymer Edition (2024) Vol. 35, Iss. 7, pp. 1031-1063
Closed Access | Times Cited: 1
Luyao Zhao, Xinyue Wang, Meiling Wen, et al.
Journal of Biomaterials Science Polymer Edition (2024) Vol. 35, Iss. 7, pp. 1031-1063
Closed Access | Times Cited: 1
piRNA-823 exerts protective effects on high glucose concentration–induced HUVEC pyroptosis by targeting LCN2
Yao Tan, Qian Zeng, Xinguo Sun, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Yao Tan, Qian Zeng, Xinguo Sun, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Recent Advances of Using Exosomes as Diagnostic Markers and Targeting Carriers for Cardiovascular Disease
Ni Li, Tianyuan Zhang, Linwen Zhu, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 9, pp. 4354-4372
Closed Access | Times Cited: 4
Ni Li, Tianyuan Zhang, Linwen Zhu, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 9, pp. 4354-4372
Closed Access | Times Cited: 4
Advances in the Management of Heart Failure with Reduced Ejection Fraction; The Role of SGLT2is, ARNI, Myotropes, Vericiguat, and Anti-inflammatory Agents: A Mini-review
Dimitrios A. Vrachatis, Konstantinos A. Papathanasiou, Sotiria G. Giotaki, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 7, pp. 509-518
Closed Access | Times Cited: 3
Dimitrios A. Vrachatis, Konstantinos A. Papathanasiou, Sotiria G. Giotaki, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 7, pp. 509-518
Closed Access | Times Cited: 3
Mechanisms and Optimization Strategies of Paracrine Exosomes from Mesenchymal Stem Cells in Ischemic Heart Disease
Xiaorong Yin, Lizhi Lin, Fang Fang, et al.
Stem Cells International (2023) Vol. 2023, pp. 1-20
Open Access | Times Cited: 3
Xiaorong Yin, Lizhi Lin, Fang Fang, et al.
Stem Cells International (2023) Vol. 2023, pp. 1-20
Open Access | Times Cited: 3
Fibroblast-derived extracellular vesicles as trackable efficient transporters of an experimental nanodrug with fibrotic heart and lung targeting
Jorge RuizdelRio, Gabriela Guedes, Danielle Novillo, et al.
Theranostics (2023) Vol. 14, Iss. 1, pp. 176-202
Open Access | Times Cited: 2
Jorge RuizdelRio, Gabriela Guedes, Danielle Novillo, et al.
Theranostics (2023) Vol. 14, Iss. 1, pp. 176-202
Open Access | Times Cited: 2
Advances in the study of miRNAs in chronic kidney disease with cardiovascular complications
Chenchen Zou
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 2
Chenchen Zou
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 2
Circulating Extracellular Vesicles from Heart Failure Patients Inhibit Human Cardiomyocyte Activities
Zhen Ke, Xiaojuan Wei, Zelun Zhi, et al.
Journal of Cardiovascular Translational Research (2024)
Open Access
Zhen Ke, Xiaojuan Wei, Zelun Zhi, et al.
Journal of Cardiovascular Translational Research (2024)
Open Access
